HSV-1 and HSV-2 are two types of herpes simplex virus, a common infection that stays in your body for life. HSV-1 typically causes oral herpes (cold sores), while HSV-2 typically causes genital herpes, though either type can infect either location. Globally, over 846 million people between ages 15 and 49 have a genital herpes infection alone, making this one of the most widespread viral infections in the world.
How HSV-1 and HSV-2 Differ
Both viruses belong to the same family and behave similarly at the cellular level. They infect nerve cells, go dormant, and periodically reactivate to cause outbreaks. The key differences come down to where they prefer to live and how they spread.
HSV-1 spreads mainly through contact with saliva, sores, or skin around the mouth. Kissing, sharing utensils, or touching an active cold sore are common routes. It can also spread to the genitals through oral sex, which is increasingly common. An estimated 376 million people worldwide have genital HSV-1 infections.
HSV-2 spreads primarily through sexual contact with genital or anal skin, sores, or fluids. It rarely infects the mouth. Around 520 million people globally carry genital HSV-2.
You can carry both types at the same time. Roughly 50 million people with genital HSV-1 also have HSV-2.
What Outbreaks Feel and Look Like
After exposure, symptoms typically appear within six to eight days, though the incubation period can range from one to 26 days. Many people never notice their first infection at all, or mistake it for something else entirely.
When symptoms do appear, the pattern is similar for both types. Up to 48 hours before blisters show up, you may feel tingling, itching, or burning at the site. For genital herpes, this prodromal phase can also include fever, headache, and swollen lymph nodes. Then small, fluid-filled blisters develop, break open into shallow sores, and gradually crust over and heal.
First outbreaks tend to be the most painful and last the longest. Recurrences are usually shorter and milder. HSV-2 recurs more frequently than HSV-1 when it infects the genitals, which is one of the meaningful clinical differences between the two types.
Spreading Without Symptoms
One of the most important things to understand about herpes is that the virus can spread even when no sores are visible. This is called viral shedding, and it happens on days when you feel completely fine.
The shedding rates differ substantially between the two types. Research from the University of Washington tracked people who swabbed daily and found that HSV-2 sheds on roughly 34% of days in the first year after infection, dropping to about 17% of days at the ten-year mark. HSV-1 genital infections shed far less: about 12% of days at two months, falling to 7% at eleven months and just 1.3% of days by two years. In most cases, participants had no symptoms during shedding episodes.
This difference in shedding frequency is a major reason HSV-2 spreads more easily between sexual partners than genital HSV-1.
How Herpes Is Diagnosed
If you have an active sore, the most reliable approach is a swab test. A healthcare provider takes a sample from a blister or sore that hasn’t yet crusted over, and the lab checks it for viral DNA. These swab-based tests work best on fresh lesions.
Blood tests detect antibodies your immune system makes in response to the virus, but they have a significant limitation: it can take up to 16 weeks after exposure for current blood tests to pick up an infection. A negative blood test soon after a possible exposure doesn’t rule anything out. Blood tests can also distinguish between HSV-1 and HSV-2, which matters for understanding your risk of recurrence and transmission.
Treatment and Daily Management
There’s no cure for herpes, but antiviral medications can shorten outbreaks and reduce how often they happen. Two main approaches exist: episodic therapy and suppressive therapy.
Episodic therapy means taking medication at the first sign of an outbreak (ideally during that tingling or itching phase) and continuing for a few days. This can cut the duration and severity of the episode. Suppressive therapy means taking a lower dose of antiviral medication every day, whether or not you’re having an outbreak. Daily suppressive therapy reduces the frequency of outbreaks and lowers the amount of viral shedding, which can help protect sexual partners.
For many people, outbreaks become less frequent over time even without daily medication. Some people have one or two outbreaks a year, while others go years between episodes. The decision between episodic and suppressive treatment depends on how often outbreaks occur and whether reducing transmission risk to a partner is a priority.
Reducing Transmission Risk
Consistent condom use lowers the risk of HSV-2 transmission, though not as dramatically as it does for some other infections because herpes can spread from skin not covered by a condom. Studies show that people who use condoms more frequently have a lower risk of acquiring HSV-2 compared to less frequent users, with one large study finding a 26% reduction in risk among those with higher condom use. The protective effect appears stronger for women than for men.
Avoiding sexual contact during active outbreaks is the single most effective step, since viral load is highest when sores are present. Combining daily antiviral medication with condom use offers the best overall risk reduction for couples where one partner has herpes and the other doesn’t.
Pregnancy and Newborn Risk
Herpes can, in rare cases, be transmitted from mother to baby during delivery. The risk depends heavily on timing. Women who acquire herpes for the first time near the end of pregnancy pose the greatest danger to their newborn because their bodies haven’t yet built up protective antibodies. In these cases, the transmission rate is roughly 1 in 1,900 deliveries. Women with longstanding HSV-2 infections transmit to their infants far less often, at about 2 in 5,761 deliveries, because maternal antibodies cross the placenta and offer the baby some protection.
Neonatal herpes, while rare, can be serious. This is why providers screen for herpes symptoms during late pregnancy and may recommend antiviral medication or cesarean delivery for women with active lesions at the time of labor.